{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:00:10Z","timestamp":1781478010251,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,15]]},"DOI":"10.7759\/cureus.62452","type":"journal-article","created":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T02:39:17Z","timestamp":1718505557000},"source":"Crossref","is-referenced-by-count":2,"title":["Challenges and Implications for Substance Use and Mental Healthcare Among Under-Resourced Women in the COVID-19 Era"],"prefix":"10.7759","author":[{"given":"Maria C","family":"Mejia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Kowalchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra J","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muktha","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Scamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000685","article-title":"Innovation during COVID-19: improving addiction treatment access","volume":"14","author":"Samuels EA","year":"2020","unstructured":"Samuels EA, Clark SA, Wunsch C, Jordison Keeler LA, Reddy N, Vanjani R, Wightman RS. Innovation during COVID-19: improving addiction treatment access. J Addict Med. 2020, 14:e8-9. 10.1097\/ADM.0000000000000685","journal-title":"J Addict Med"},{"key":"ref2","article-title":"Disaster Technical Assistance Center supplemental Research Bulletin: a preliminary look at the mental health and substance use-related effects of the COVID-19 pandemic","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2021","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Disaster Technical Assistance Center supplemental Research Bulletin: a preliminary look at the mental health and substance use-related effects of the COVID-19 pandemic. SAMHSA, Rockville, MD; 2021."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.19632","article-title":"Mental health disorders related to COVID-19-related deaths","volume":"324","author":"Simon NM","year":"2020","unstructured":"Simon NM, Saxe GN, Marmar CR. Mental health disorders related to COVID-19-related deaths. JAMA. 2020, 324:1493-4. 10.1001\/jama.2020.19632","journal-title":"JAMA"},{"key":"ref4","unstructured":"Substance Abuse and Mental Health Services Administration. 2022 NSDUH Annual National Report. (2023). Accessed: May 2, 2024: https:\/\/www.samhsa.gov\/data\/report\/2022-nsduh-annual-national-report."},{"key":"ref5","article-title":"Health Canada, Public Health Agency of Canada, and U.S. Department of Health and Human Services. Canada-U.S. Joint White Paper: Substance Use and Harms During COVID-19 and Approaches to Federal Surveillance and Response","author":"Health Canada","year":"2022","unstructured":"Health Canada, Public Health Agency of Canada, and U.S. Department of Health and Human Services. Canada-U.S. Joint white paper: substance use and harms during COVID-19 and approaches to federal surveillance and response. US Department of Health and Human Services, Office of the Assistant Secretary for Health, Ottawa, Ontario; 2022. https:\/\/www.hhs.gov\/overdose-prevention\/sites\/default\/files\/documents\/canada-us-joint-white-paper-substance-use-harms...."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11495-0","article-title":"Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies","volume":"21","author":"Henderson R","year":"2021","unstructured":"Henderson R, McInnes A, Mackey L, et al.. Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies. BMC Public Health. 2021, 21:1471. 10.1186\/s12889-021-11495-0","journal-title":"BMC Public Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13099","article-title":"Alcohol use in Australia during the early days of the COVID-19 pandemic: initial results from the COLLATE project","volume":"74","author":"Neill E","year":"2020","unstructured":"Neill E, Meyer D, Toh WL, van Rheenen TE, Phillipou A, Tan EJ, Rossell SL. Alcohol use in Australia during the early days of the COVID-19 pandemic: initial results from the COLLATE project. Psychiatry Clin Neurosci. 2020, 74:542-9. 10.1111\/pcn.13099","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106532","article-title":"Drinking to cope with the pandemic: the unique associations of COVID-19-related perceived threat and psychological distress to drinking behaviors in American men and women","volume":"110","author":"Rodriguez LM","year":"2020","unstructured":"Rodriguez LM, Litt DM, Stewart SH. Drinking to cope with the pandemic: the unique associations of COVID-19-related perceived threat and psychological distress to drinking behaviors in American men and women. Addict Behav. 2020, 110:106532. 10.1016\/j.addbeh.2020.106532","journal-title":"Addict Behav"},{"key":"ref9","unstructured":"KFF. The implications of COVID-19 for mental health and substance use. (2021). Accessed: October 10, 2022: https:\/\/www.kff.org\/mental-health\/issue-brief\/the-implications-of-covid-19-for-mental-health-and-substance-use\/."},{"key":"ref10","unstructured":"Pew Research Center. at least four-in-ten U.S. adults have faced high levels of psychological distress during COVID-19 pandemic. (2022). Accessed: April 11, 2024: https:\/\/www.pewresearch.org\/short-reads\/2022\/12\/12\/at-least-four-in-ten-u-s-adults-have-faced-high-levels-of-psycholo...."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/acer.14839","article-title":"Longitudinal assessment of drinking changes during the pandemic: the 2021 COVID-19 follow-up study to the 2019 to 2020 National Alcohol Survey","volume":"46","author":"Kerr WC","year":"2022","unstructured":"Kerr WC, Ye Y, Martinez P, Karriker-Jaffe KJ, Patterson D, Greenfield TK, Mulia N. Longitudinal assessment of drinking changes during the pandemic: the 2021 COVID-19 follow-up study to the 2019 to 2020 National Alcohol Survey. Alcohol Clin Exp Res. 2022, 46:1050-61. 10.1111\/acer.14839","journal-title":"Alcohol Clin Exp Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108378","article-title":"Recovering from substance use disorders during the early months of the COVID-19 pandemic: a mixed-methods longitudinal study of women in Kansas City","volume":"129","author":"Hurley EA","year":"2021","unstructured":"Hurley EA, Pi\u00f1a K, Cegielski V, Noel-MacDonnell JR, Miller MK. Recovering from substance use disorders during the early months of the COVID-19 pandemic: a mixed-methods longitudinal study of women in Kansas City. J Subst Abuse Treat. 2021, 129:108378. 10.1016\/j.jsat.2021.108378","journal-title":"J Subst Abuse Treat"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.32598\/bcn.11.covid19.2543.1","article-title":"Psychological impact of the acute COVID-19 period on patients with substance use disorders: we are all in this together","volume":"11","author":"DeJong CA","year":"2020","unstructured":"DeJong CA, DeJong Verhagen JG, Pols R, Verbrugge CA, Baldacchino A. Psychological impact of the acute COVID-19 period on patients with substance use disorders: we are all in this together. Basic Clin Neurosci. 2020, 11:207-16. 10.32598\/bcn.11.covid19.2543.1","journal-title":"Basic Clin Neurosci"},{"key":"ref14","unstructured":"Centers for Disease and Control Prevention. How to protect yourself and others. (2021). Accessed: August 31, 2021: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/prevent-getting-sick\/prevention.html."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009, 42:377-81. 10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al.. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019, 95:103208. 10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"ref17","unstructured":"NIDA. Substance use in women research report. (2021). Accessed: April 11, 2024: https:\/\/nida.nih.gov\/publications\/research-reports\/substance-use-in-women\/summary."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2017.10.012","article-title":"Sex and gender differences in substance use disorders","volume":"66","author":"McHugh RK","year":"2018","unstructured":"McHugh RK, Votaw VR, Sugarman DE, Greenfield SF. Sex and gender differences in substance use disorders. Clin Psychol Rev. 2018, 66:12-23. 10.1016\/j.cpr.2017.10.012","journal-title":"Clin Psychol Rev"},{"key":"ref19","article-title":"Report to the community on the Houston area domestic violence providers study initial local DV data aggregation","author":"Gregory E","year":"2023","unstructured":"Gregory E, Hough Z, Martinez I. Report to the community on the Houston area domestic violence providers study initial local DV data aggregation. The University of Houston, Institute for Research on Women, Gender, and Sexuality, Houston, TX; 2023."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States","volume":"26","author":"Wang QQ","year":"2021","unstructured":"Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2021, 26:30-9. 10.1038\/s41380-020-00880-7","journal-title":"Mol Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.202000534","article-title":"The impact of substance use disorder on COVID-19 outcomes","volume":"72","author":"Baillargeon J","year":"2021","unstructured":"Baillargeon J, Polychronopoulou E, Kuo YF, Raji MA. The impact of substance use disorder on COVID-19 outcomes. Psychiatr Serv. 2021, 72:578-81. 10.1176\/appi.ps.202000534","journal-title":"Psychiatr Serv"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20921","article-title":"Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021","volume":"21","author":"Wang L","year":"2022","unstructured":"Wang L, Wang Q, Davis PB, Volkow ND, Xu R. Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021. World Psychiatry. 2022, 21:124-32. 10.1002\/wps.20921","journal-title":"World Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30144-9","article-title":"Public health messaging and harm reduction in the time of COVID-19","volume":"7","author":"Karamouzian M","year":"2020","unstructured":"Karamouzian M, Johnson C, Kerr T. Public health messaging and harm reduction in the time of COVID-19. Lancet Psychiatry. 2020, 7:390-1. 10.1016\/S2215-0366(20)30144-9","journal-title":"Lancet Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108617","article-title":"Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder","volume":"221","author":"Jacka BP","year":"2021","unstructured":"Jacka BP, Janssen T, Garner BR, et al.. Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder. Drug Alcohol Depend. 2021, 221:108617. 10.1016\/j.drugalcdep.2021.108617","journal-title":"Drug Alcohol Depend"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000684","article-title":"Opioid use disorder and COVID-19: crashing of the crises","volume":"14","author":"Khatri UG","year":"2020","unstructured":"Khatri UG, Perrone J. Opioid use disorder and COVID-19: crashing of the crises. J Addict Med. 2020, 14:e6-7. 10.1097\/ADM.0000000000000684","journal-title":"J Addict Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108180","article-title":"COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns","volume":"121","author":"Mellis AM","year":"2021","unstructured":"Mellis AM, Potenza MN, Hulsey JN. COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns. J Subst Abuse Treat. 2021, 121:108180. 10.1016\/j.jsat.2020.108180","journal-title":"J Subst Abuse Treat"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108273","article-title":"Integrated substance use and prenatal care delivery in the era of COVID-19","volume":"124","author":"Patton EW","year":"2021","unstructured":"Patton EW, Saia K, Stein MD. Integrated substance use and prenatal care delivery in the era of COVID-19. J Subst Abuse Treat. 2021, 124:108273. 10.1016\/j.jsat.2020.108273","journal-title":"J Subst Abuse Treat"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108200","article-title":"Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: lessons learned from psychology trainees in an integrated OBGYN\/substance use disorder outpatient treatment program","volume":"122","author":"Sadicario JS","year":"2021","unstructured":"Sadicario JS, Parlier-Ahmad AB, Brechbiel JK, Islam LZ, Martin CE. Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: lessons learned from psychology trainees in an integrated OBGYN\/substance use disorder outpatient treatment program. J Subst Abuse Treat. 2021, 122:108200. 10.1016\/j.jsat.2020.108200","journal-title":"J Subst Abuse Treat"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51213","article-title":"Challenges in delivering telemedicine to vulnerable populations: experiences of an addiction medical service during COVID-19","volume":"215","author":"Hew A","year":"2021","unstructured":"Hew A, Arunogiri S, Lubman DI. Challenges in delivering telemedicine to vulnerable populations: experiences of an addiction medical service during COVID-19. Med J Aust. 2021, 215:237-237.e1. 10.5694\/mja2.51213","journal-title":"Med J Aust"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ph13070155","article-title":"Substance use disorder in the COVID-19 pandemic: a systematic review of vulnerabilities and complications","volume":"13","author":"Wei Y","year":"2020","unstructured":"Wei Y, Shah R. Substance use disorder in the COVID-19 pandemic: a systematic review of vulnerabilities and complications. Pharmaceuticals (Basel). 2020, 13:10.3390\/ph13070155","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/248764-challenges-and-implications-for-substance-use-and-mental-healthcare-among-under-resourced-women-in-the-covid-19-era","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T02:39:28Z","timestamp":1718505568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/248764-challenges-and-implications-for-substance-use-and-mental-healthcare-among-under-resourced-women-in-the-covid-19-era"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.62452","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,15]]}}}